ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983

Grossman Leads Neuro-Oncology Society; NYU Recruits Radiation Oncology Director.

January 14, 2000

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012

Raising NIH Appropriations Is High Priority, House Subcommittee Chairman Says

March 7, 1997

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

November 20, 1981